Introduction
The decreased adoption rate of Saama's Clinical AI platform among new pharmaceutical clients this quarter is a critical issue that requires immediate attention. To address this problem, I'll employ a systematic approach to identify, validate, and resolve the root cause while considering both short-term and long-term implications for our product strategy.
This analysis follows a structured approach covering issue identification, hypothesis generation, validation, and solution development.
Step 1
Clarifying Questions (3 minutes)
Why it matters: Recent changes could directly impact adoption rates. Expected answer: Yes, we launched a new pricing tier. Impact on approach: If confirmed, we'd focus on pricing sensitivity and value perception.
Why it matters: Changes in target audience could explain adoption rate fluctuations. Expected answer: We've been focusing more on smaller biotech companies. Impact on approach: If true, we'd need to assess product-market fit for this segment.
Why it matters: Competitive actions could be drawing potential clients away. Expected answer: One competitor introduced an AI-powered trial design feature. Impact on approach: We'd need to evaluate our product positioning and feature set.
Why it matters: Changes in the sales process could directly impact adoption rates. Expected answer: We've seen a decrease in demo-to-trial conversions. Impact on approach: We'd focus on improving our demo experience and follow-up process.
Practice similar questions
Subscribe to access the full answer